Amporn Atsawarungruangkit
Overview
    Explore the profile of Amporn Atsawarungruangkit including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              22
            
            
              Citations
              122
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Patel N, Leffler D, Al-Toma A, Mulder C, Elli L, Gan G, et al.
  
  
    Am J Surg Pathol
    . 2023 Nov;
          48(2):212-220.
    
    PMID: 37994653
  
  
          Validated nonbiopsy methods to assure duodenal mucosal healing in celiac disease are lacking, yet ongoing mucosal injury is associated with anemia, osteoporosis, and lymphoma. Most providers utilize clinical data as...
      
2.
        
    
    Atsawarungruangkit A, Laoveeravat P, Promrat K
  
  
    World J Hepatol
    . 2021 Nov;
          13(10):1417-1427.
    
    PMID: 34786176
  
  
          Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting over 30% of the United States population. Early patient identification using a simple method is highly...
      
3.
        
    
    Atsawarungruangkit A, Elfanagely Y, Pan J, Anderson K, Scharfen J, Promrat K
  
  
    World J Hepatol
    . 2021 Aug;
          13(7):790-803.
    
    PMID: 34367500
  
  
          Background: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children and adolescents. Aim: To determine the prevalence and risk factors of steatosis and advanced...
      
4.
        
    
    Elfanagely Y, Atsawarungruangkit A, Moss S
  
  
    Gastroenterology
    . 2021 Feb;
          160(6):1917-1921.
    
    PMID: 33548237
  
  
          No abstract available.
      
5.
        
    
    Elfanagely Y, Atsawarungruangkit A, Scharfen J, Pavlech L, Moss S
  
  
    Dig Dis Sci
    . 2020 Nov;
          66(11):3689-3697.
    
    PMID: 33236316
  
  
          Background: Obstructive sleep apnea (OSA) has gastrointestinal implications as it is associated with gastroesophageal reflux disease. Less certain is an independent association between OSA and Barrett's esophagus. We performed a...
      
6.
        
    
    Atsawarungruangkit A, Yuan J, Kodama T, Cheng M, Mansouri M, Han B, et al.
  
  
    J Int Med Res
    . 2020 Sep;
          48(8):300060520938943.
    
    PMID: 32865095
  
  
          Background: The outbreak of coronavirus disease 2019 (COVID-19) began in December 2019 and continues to spread worldwide. Rapid and accurate identification of suspected cases is critical in slowing spread of...
      
7.
        
    
    Atsawarungruangkit A, Silvester J, Weiten D, Green K, Wilkey K, Rigaux L, et al.
  
  
    Nutrition
    . 2020 Jun;
          78:110819.
    
    PMID: 32544849
  
  
          Objectives: Celiac disease (CD) treatment involves a gluten-free diet (GFD). There is no standardized tool for dietitians to objectively grade GFD adherence. This study aimed to develop a standardized tool...
      
8.
        
    
    Atsawarungruangkit A, Habr F
  
  
    Gastroenterology
    . 2020 Mar;
          158(8):2307-2308.
    
    PMID: 32201179
  
  
          No abstract available.
      
9.
        
    C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population
  
  
    
    Atsawarungruangkit A, Chenbhanich J, Dickstein G
  
  
    World J Gastroenterol
    . 2018 Sep;
          24(32):3663-3670.
    
    PMID: 30166861
  
  
          Aim: To determine whether fasting C-peptide is an independent predictor for non-alcoholic fatty liver disease (NAFLD) in United States population. Methods: Using the National Health and Nutrition Examination Survey (NHANES)...
      
10.
        
    
    Permpalung N, Mahoney M, McCoy C, Atsawarungruangkit A, Gold H, Levine J, et al.
  
  
    Leuk Lymphoma
    . 2018 Jun;
          60(1):85-91.
    
    PMID: 29947555
  
  
          Palivizumab has been used to treat respiratory syncytial virus (RSV)-infected hematologic malignancy patients at our institution based on limited published data. We conducted this retrospective study to evaluate clinical outcomes...